Page last updated: 2024-10-19

phosphorylcholine and Birth Weight

phosphorylcholine has been researched along with Birth Weight in 9 studies

Phosphorylcholine: Calcium and magnesium salts used therapeutically in hepatobiliary dysfunction.
phosphocholine : The phosphate of choline; and the parent compound of the phosphocholine family.

Birth Weight: The mass or quantity of heaviness of an individual at BIRTH. It is expressed by units of pounds or kilograms.

Research Excerpts

ExcerptRelevanceReference
" We conclude that after giving two doses of Exosurf, further doses might best be delayed until after two days, and that further clinical evaluation of dosage regimens is required."2.67Turnover of exogenous artificial surfactant. ( Ashton, MR; Austin, NC; Hall, MA; Normand, IC; Postle, AD; Smith, DE, 1992)

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's8 (88.89)18.2507
2000's1 (11.11)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Courtney, SE1
Long, W2
McMillan, D1
Walter, D2
Thompson, T1
Sauve, R1
Conway, B1
Bard, H2
Wach, R1
Darlow, B1
Bourchier, D1
Broadbent, R1
Knight, D1
Selby, R1
Cotton, RB1
Olsson, T1
Law, AB1
Parker, RA1
Lindstrom, DP1
Silberberg, AR1
Sundell, HW1
Sandberg, K1
Rossello, JD1
Hayward, PE1
Martell, M1
Del Barco, M1
Margotto, P1
Grandzoto, J1
Bastida, J1
Peña, J1
Villanueva, D1
Hamdan, AH1
Shaw, NJ1
Murdoch, E1
Kempley, ST1
Ashton, MR1
Postle, AD1
Hall, MA1
Austin, NC1
Smith, DE1
Normand, IC1
Corbet, A1
Cotton, R1
Courtney, S1
McGuiness, G1
Watts, J1
Smyth, J1
Chernick, V1
Phibbs, RH1
Ballard, RA1
Clements, JA1
Heilbron, DC1
Phibbs, CS1
Schlueter, MA1
Sniderman, SH1
Tooley, WH1
Wakeley, A1

Trials

9 trials available for phosphorylcholine and Birth Weight

ArticleYear
Double-blind 1-year follow-up of 1540 infants with respiratory distress syndrome randomized to rescue treatment with two doses of synthetic surfactant or air in four clinical trials. American and Canadian Exosurf Neonatal Study Groups.
    The Journal of pediatrics, 1995, Volume: 126, Issue:5 Pt 2

    Topics: Air; Birth Weight; Child Development; Double-Blind Method; Drug Combinations; Fatty Alcohols; Female

1995
Respiratory distress syndrome in New Zealand: evidence from the OSIRIS trial of exogenous surfactant (Exosurf).
    The New Zealand medical journal, 1994, Jun-22, Volume: 107, Issue:980

    Topics: Birth Weight; Cerebral Hemorrhage; Cohort Studies; Cost of Illness; Drug Combinations; Fatty Alcohol

1994
The physiologic effects of surfactant treatment on gas exchange in newborn premature infants with hyaline membrane disease.
    Pediatric research, 1993, Volume: 34, Issue:4

    Topics: Biological Products; Birth Weight; Drug Combinations; Fatty Alcohols; Female; Gestational Age; Human

1993
Hyaline membrane disease (HMD) therapy in Latin America: impact of exogenous surfactant administration on newborn survival, morbidity and use of resources.
    Journal of perinatal medicine, 1997, Volume: 25, Issue:3

    Topics: Birth Weight; Drug Combinations; Fatty Alcohols; Female; Humans; Hyaline Membrane Disease; Infant Mo

1997
Changes in pulmonary artery pressure during the acute phase of respiratory distress syndrome treated with three different types of surfactant.
    Pediatric pulmonology, 1998, Volume: 25, Issue:3

    Topics: Acceleration; Biological Products; Birth Weight; Blood Pressure; Cardiac Output; Drug Combinations;

1998
The effects of synthetic and natural surfactant on fluid balance in acute respiratory distress syndrome.
    European journal of pediatrics, 2000, Volume: 159, Issue:10

    Topics: Biological Products; Birth Weight; Diuresis; Drug Combinations; Fatty Alcohols; Gestational Age; Hum

2000
Turnover of exogenous artificial surfactant.
    Archives of disease in childhood, 1992, Volume: 67, Issue:4 Spec No

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Birth Weight; Chromatography, High Pressure Liquid; Drug Combina

1992
A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
    The New England journal of medicine, 1991, Dec-12, Volume: 325, Issue:24

    Topics: Birth Weight; Bronchopulmonary Dysplasia; Child; Drug Combinations; Fatty Alcohols; Female; Follow-U

1991
Initial clinical trial of EXOSURF, a protein-free synthetic surfactant, for the prophylaxis and early treatment of hyaline membrane disease.
    Pediatrics, 1991, Volume: 88, Issue:1

    Topics: Administration, Inhalation; Birth Weight; Drug Combinations; Drug Evaluation; Fatty Alcohols; Follow

1991